1. The clinical and financial cost of mental disorders among elderly patients with gastrointestinal malignancies
- Author
-
Harris, Jeremy P, Kashyap, Mehr, Humphreys, Jessica N, Pollom, Erqi L, and Chang, Daniel T
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Digestive Diseases ,Mental Health ,Clinical Research ,Cancer ,Health Services ,Behavioral and Social Science ,Colo-Rectal Cancer ,Brain Disorders ,Mental health ,Good Health and Well Being ,Age Factors ,Aged ,Aged ,80 and over ,Comorbidity ,Databases ,Factual ,Female ,Financial Stress ,Gastrointestinal Neoplasms ,Health Care Costs ,Health Expenditures ,Humans ,Male ,Medicare ,Mental Disorders ,Prognosis ,Retrospective Studies ,Risk Assessment ,Risk Factors ,SEER Program ,Time Factors ,United States ,colon cancer ,financial toxicity ,gastrointestinal cancer ,mental disorder ,SEER-Medicare ,Biochemistry and Cell Biology ,Oncology and carcinogenesis - Abstract
The clinical and financial effects of mental disorders are largely unknown among gastrointestinal (GI) cancer patients. Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database, we identified patients whose first cancer was a primary colorectal, pancreatic, gastric, hepatic/biliary, esophageal, or anal cancer as well as those with coexisting depression, anxiety, psychotic, or bipolar disorder. Survival, chemotherapy use, total healthcare expenditures, and patient out-of-pocket expenditures were estimated and compared based on the presence of a mental disorder. We identified 112,283 patients, 23,726 (21%) of whom had a coexisting mental disorder. Median survival for patients without a mental disorder was 52 months (95% CI 50-53 months) and for patients with a mental disorder was 43 months (95% CI 42-44 months) (p
- Published
- 2020